$MKTW

MARKETWISE, INC. (MKTW): Results of Operations and Financial Condition

MARKETWISE, INC. (MKTW) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991-financialandope.htm EX-99.1 Document MarketWise, Inc. Reports Preliminary Selected Unaudited Second Quarter Results With Paid Subscriber Growth Continuing In The Second Quarter 2026; Billings Increased 56% Year-Over-Year To Approximately $91 million ; Raises

Original reporting
Published Jul 9, 2026, 9:34 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 10, 2026, 10:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$MKTW
Bullish
high confidence
Mentioned
$MKTW
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$MKTWBullishMed
01

Why it matters

The key decision-relevant items are the preliminary Q2 billings performance and the raised FY2026 billings guidance, plus management commentary on toggling between growth and margin and moderating acquisition spend in H2.

02

Market read

Guidance increase to $330M FY2026 billings and strong Q2 billings growth (+56% YoY) can drive estimate revisions and near-term positioning ahead of the Aug 6 earnings print.

03

What to watch

Paid subscriber growth is modest sequentially (7% from Dec 31) while ARPU rose sharply; traders should watch whether ARPU sustainability depends on mix shifts or retention that could fade after acquisition spend moderation.

Relevance 7/10Novelty 8/10Timing: ahead of the Aug 6, 2026 Q2 earnings press release

Background

This is an SEC Form 8-K (Item 2.02) with an exhibit providing preliminary selected unaudited Q2 2026 operational and financial updates before the full earnings release.

Company-level read

Ticker impact

$MKTWBullishHigh confidence
Context

MarketWise preliminarily reports Q2 billings of about $91M (+56% YoY) and raises FY2026 billings guidance to $330M (+10%).

Expected impact

Bias toward upside repricing into the Aug 6 earnings date, with volatility risk if margins or subscriber trends disappoint versus the raised billings target.

Evidence & confidence

The filing is a primary disclosure (SEC 8-K) with specific preliminary operating metrics (paid subscribers, billings, ARPU) and an explicit FY2026 billings guidance increase, which are direct inputs to valuation and near-term estimates.

Market effects

Supports the narrative that digital financial subscription models can re-accelerate billings via acquisition and retention, potentially improving sentiment for similar self-directed investor platforms.

Limited, primarily company-specific for a US-listed microcap.

Low; no cross-border operational or regulatory developments disclosed.

Counterpoint

Preliminary results and guidance are subject to accounting adjustments, and management also signals lower margins in H1 with an expectation of margin improvement only in H2.

Key entities

  • MarketWise, Inc.

    NASDAQ-listed multi-brand digital subscription services platform; filed preliminary Q2 results and raised FY2026 billings guidance.

Related articles

$KDMed

Kyndryl Q1 Earnings Call Highlights

Kyndryl (NYSE:KD) Q1 call said demand is rising for AI deployment, hybrid modernization, cybersecurity and data-residency. It reported 40 deals worth over $50M in 12 months, with 10 in Q1, and Kyndryl Consult signings up 50%. IBM relationship changes are expected to weigh on constant-currency revenue through FY2027. FCF was -$401M; cash $2.1B. Outlook FY2027 reaffirmed.

$KAIMedAI 8/10

Kadant Q2 Earnings Call Highlights

Kadant (NYSE:KAI) reported Q2 equipment backlog of $182 million and said aftermarket demand stayed at record or near-record levels. Flow Control revenue rose 5% to $100 million; Industrial Processing revenue rose to a record $144 million; Material Handling bookings were $73 million. Q2 gross margin fell to 43.8%. Kadant raised FY revenue guidance to $1.19-$1.21B and adjusted EPS to $12.43-$12.68.

$KRPMed

Kimbell Royalty Q2 Earnings Call Highlights

Kimbell Royalty (NYSE:KRP) reported record Q2 adjusted EBITDA of $84.9 million, with cash G&A of $5.9 million ($2.50 per BOE). It declared a $0.47 per common unit cash distribution, up 15% QoQ, and said 47% may be return of capital. The borrowing base rose to $660 million; debt was $478.7 million. Rig activity and production varied by basin.

$KMPRMed

Kemper Q2 Earnings Call Highlights

Kemper (NYSE:KMPR) reported Q2 results and discussed credit-loss allowances tied to surplus notes in its reciprocal exchange, including a $21 million pre-tax charge on $36 million of notes. Holding-company liquidity was $766 million and debt-to-capital rose to 28.3%. Personal auto normalized combined ratio was 102% and commercial 93.7%, with California rate actions and restructuring savings over $80 million run-rate.

$KOPMed

Koppers Q2 Earnings Call Highlights

Koppers (NYSE:KOP) reported Q2 updates on capital spending of about $24M, shareholder returns of $47M, and debt reduction of $22M in the first half. Liquidity was $390M with net debt of $857M and net leverage at 3.5x. The board raised its dividend to $0.09/share. KOP kept 2026 sales guidance at $1.9B-$2.0B but cut adjusted EBITDA to $240M-$250M and EPS to $3.80-$4.20.